Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Option Care Health, the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President of Investor Relations effective May 26, 2026. Okunski brings over two decades of investor relations experience across healthcare, technology and energy sectors, and will lead the company's investor relations strategy and stakeholder communications.

06/04/2026, 7:00 AM • GlobeNewswire

OPCH SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Law firm Kirby McInerney LLP is investigating Option Care Health for potential securities law violations following a significant stock price decline. The company issued optimistic guidance in February 2026 but missed Q1 earnings expectations in April, causing shares to drop 24%. The firm is seeking investors who purchased OPCH securities to discuss potential claims.

05/14/2026, 8:00 PM • GlobeNewswire

Levi & Korsinsky Announces Investigation of Securities Claims Against Option Care Health (OPCH)

Option Care Health (OPCH) shares fell approximately 26-30% after the company reported a Q1 2026 revenue miss and slashed full-year 2026 guidance by $125-225 million, down from $5.8-6.0 billion to $5.675-5.775 billion. The significant guidance cut came just two months after management reaffirmed the original guidance on the Q4 2025 earnings call. Levi & Korsinsky has initiated a securities fraud investigation examining whether the company made materially false or misleading statements regarding patient census changes and Stelara patient conversions.

05/14/2026, 9:00 AM • GlobeNewswire

GE HealthCare Technologies Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP announced investigations into GE HealthCare Technologies, Option Care Health, and Rocky Brands on behalf of investors who suffered losses. GE HealthCare disclosed significantly reduced earnings guidance and a $250 million increase in expected input costs due to inflation, leading to a sharp stock price decline.

04/30/2026, 7:15 PM • GlobeNewswire

Option Care Health, Inc. Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation

Option Care Health's stock fell over 30% on April 30, 2026, after the company reported weaker-than-expected first quarter results and cut full year revenue guidance due to a larger than anticipated patient census reset in its chronic inflammatory disease portfolio. Block & Leviton is investigating potential securities law violations and encouraging affected investors to contact them.

04/30/2026, 12:52 PM • GlobeNewswire

Why Option Care Health Stock Zoomed 8% Higher on Tuesday

Option Care Health (OPCH) stock surged 8% on Tuesday following the announcement of preliminary Q4 2025 financial results. The company reported net sales of $1.46-$1.47 billion (up from $1.35 billion year-over-year) and non-GAAP net income of $73.8-$79 million ($0.46-$0.49 per share). Additionally, the company doubled its share repurchase authorization to $1 billion, demonstrating confidence in its business outlook.

01/13/2026, 7:09 PM • The Motley Fool

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

Option Care Health, the largest independent home and alternate site infusion services provider, will present at the J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026.

12/12/2025, 7:00 AM • GlobeNewswire

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025

Option Care Health reported Q2 2025 financial results with net revenue of $1.42 billion, up 15.4% year-over-year. The company showed resilience in a dynamic marketplace, with adjusted diluted earnings per share of $0.41, up 10.8% from the previous year.

07/30/2025, 7:00 AM • GlobeNewswire